Skip to Main Content
An official website of the United States government
CDAS has a New Look: On December 9th, the CDAS website was updated with a new design! The update incorporates all of the existing CDAS functionality with a more modern and user friendly interface.

Is pre-biopsy MRI cost-effective relative to usual care in the diagnosis of prostate cancer?

Principal Investigator

Name
Trisha Saini

Degrees
B.S., M.S.

Institution
Weill Cornell Medical College

Position Title
Student

Email
trs4002@med.cornell.edu

About this CDAS Project

Study
PLCO (Learn more about this study)

Project ID
PLCO-466

Initial CDAS Request Approval
Apr 4, 2019

Title
Is pre-biopsy MRI cost-effective relative to usual care in the diagnosis of prostate cancer?

Summary
We are conducting a study to determine if pre-biopsy MRI is cost-effective relative to usual care (systematic biopsy) in the diagnosis of prostate cancer. The inputs from this data set will help us understand what the patient trajectory looks like over time using usual care compared to MRI to diagnose and treat prostate cancer.

Aims

This study aims to determine if MRI guided biospy is cost-effective compared to usual care.

Collaborators

Rachael Collins
Ludolph Guichard